Income Statement
KALA BIO, INC.
KALA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - |
|
Operating Expenses
|
40.98 | 39.66 | 85.60 | 141.49 | 102.59 | 94.30 | 64.72 | 39.88 |
|
Research & Development
|
22.09 | 18.59 | 17.65 | 11.52 | 18.35 | 27.28 | 29.29 | 29.01 |
|
Selling, General & Administrative
|
18.34 | 20.57 | 65.04 | 105.06 | 81.07 | 65.02 | 35.43 | 10.87 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-40.98 | -39.66 | -85.60 | -141.49 | -102.59 | -94.30 | -64.72 | -39.88 |
|
Non-Operating Income
|
2.47 | -2.54 | 36.88 | - | - | - | - | - |
|
Interest Income
|
2.06 | 2.71 | 0.66 | 0.10 | 0.49 | 2.36 | 1.69 | 0.53 |
|
Interest Expense
|
4.56 | 5.81 | 7.28 | 8.38 | 8.59 | 8.48 | 3.31 | 1.02 |
|
Other Non-Op Income / Expense
|
- | -4.26 | -0.93 | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-38.51 | -42.20 | -44.82 | -142.61 | -104.33 | -94.35 | -66.74 | -42.21 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-40.72 | -39.36 | -85.06 | -140.51 | -101.68 | -94.30 | -64.72 | -39.88 |
|
Earnings Per Share (Basic)
|
-10.15 | -17.35 | -29.48 | -2.19 | - | - | - | - |
|
Diluted EPS
|
-10.15 | -17.35 | -29.48 | -2.19 | - | - | - | - |
|
Weighted Average Shares
|
3.80 | 2.43 | 1.52 | 65.20 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
3.80 | 2.43 | 1.52 | 65.20 | - | - | - | - |
|
Comprehensive Income
|
-38.51 | -42.20 | -44.82 | -142.61 | -104.32 | - | - | - |